How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,125 results for

"Anxiety"

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological

Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity (...) psychological treatments as defined by the National Institute for Health and Care Excellence guidelines Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines Buszewicz M, Cape J, Serfaty M, Shafran R, Kabir T, Tyrer P

2017 Health Technology Assessment (HTA) Database.

2. Alpha-Stim AID for anxiety

Alpha-Stim AID for anxiety Alpha-Stim AID for anxiety Alpha-Stim AID for anxiety Medtech innovation briefing Published: 16 September 2019 www.nice.org.uk/guidance/mib193 pathways Summary Summary The technology technology described in this briefing is Alpha-Stim AID. It is used for treating anxiety, insomnia and depression. This briefing focuses only on anxiety. The inno innovativ vative aspect e aspect is that the device has a patented electrical wave pattern that is transmitted to the brain (...) using cranial electrotherapy stimulation. The intended place in ther place in therap apy y would be an alternative to or in addition to current treatment options for people with anxiety disorder. The device would be provided by primary care services and mental health outpatient services for use at home. The main points from the e main points from the evidence vidence summarised in this briefing are from 1 randomised trial and 3 observational studies including 318 adults and 30 children with anxiety

2019 National Institute for Health and Clinical Excellence - Advice

3. Non-traditional support workers delivering a brief psychosocial intervention for older people with anxiety and depression: the NOTEPAD feasibility study Full Text available with Trip Pro

Non-traditional support workers delivering a brief psychosocial intervention for older people with anxiety and depression: the NOTEPAD feasibility study Non-traditional support workers delivering a brief psychosocial intervention for older people with anxiety and depression: the NOTEPAD feasibility study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose (...) a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Third sector support workers can deliver a psychosocial intervention to older people with anxiety and depression, and it was feasible to recruit patients, but further development of recruitment strategies is needed. {{author}} {{($index , , , , , , , , , , & . Heather Burroughs 1 , Bernadette Bartlam 1 , Peter

2019 NIHR HTA programme

4. Interventions for anxiety in mainstream school-aged children with autism spectrum disorder (ASD) Full Text available with Trip Pro

Interventions for anxiety in mainstream school-aged children with autism spectrum disorder (ASD) Interventions for anxiety in mainstream school‐aged children with autism spectrum disorder: A systematic review - Hillman - 2020 - Campbell Systematic Reviews - Wiley Online Library COVID-19 campus closures: see options for to subscribed content. By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open (...) Access Interventions for anxiety in mainstream school‐aged children with autism spectrum disorder: A systematic review Corresponding Author E-mail address: Australian Council for Educational Research, Camberwell, Victoria, Australia Correspondence Petra Lietz, Australian Council for Educational Research, 186B Pulteney Street, Adelaide, SA 5000, Australia. Email: Australian Council for Educational Research, Adelaide, South Australia, Australia Australian Council for Educational Research, Adelaide

2020 Campbell Collaboration

5. Practical tips for clinicians of patients with COVID-related anxiety/distress

Practical tips for clinicians of patients with COVID-related anxiety/distress Practical tips for clinicians helping patients with COVID-related anxiety/distress - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Practical tips for clinicians helping patients with COVID-related anxiety/distress April 14, 2020 Matthew Zimmerman, Sanah Ali, Nicholas Jones and Neal Maskrey On behalf of the Oxford COVID-19 (...) Evidence Service Team Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences University of Oxford Neal Maskrey is Honorary Professor of Evidence-informed decision making, Keele University Correspondence to VERDICT The key recommendations from current guidance and research for healthcare workers supporting patients with COVID-related anxiety include: Regulating exposure to COVID-related media. Maintaining a strong social network. Looking after your body and avoiding

2020 Oxford COVID-19 Evidence Service

6. Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Mental Health: Targeted School-Based CBT | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) February 2019 Audience Adolescents and Young Adults Children/Infants Setting School (...) Strategy Counseling Health Education Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Tabs Snapshot Summary of CPSTF Finding The targeted school-based cognitive behavioral therapy programs to reduce depression and anxiety symptoms among school-aged children and adolescents who are assessed to be at increased risk for these conditions. The CPSTF also recommends , and and CBT to reduce psychological harm from traumatic events among

2020 Community Preventive Services Task Force

7. Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Mental Health: Universal School-Based CBT | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) February 2019 Audience Adolescents and Young Adults Children/Infants Setting School (...) Strategy Counseling Health Education Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Tabs Snapshot Summary of CPSTF Finding The universal school-based cognitive behavioral therapy programs to prevent or reduce depression and anxiety symptoms among school-aged children and adolescents. The CPSTF also recommends for students who are assessed to be at increased risk for these conditions, and and CBT to reduce psychological harm from

2020 Community Preventive Services Task Force

8. Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Full Text available with Trip Pro

Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive Evaluation and Reducing relapse and suicide in bipolar disorder: practical clinical approaches to identifying risk, reducing harm and engaging service users in planning and delivery of care the PARADES (Psychoeducation, Anxiety, Relapse, Advance Directive

2018 NIHR HTA programme

9. Accelerated Resolution Therapy for Post-Traumatic Stress Disorder, Anxiety Disorders, or Mood Disorders: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Accelerated Resolution Therapy for Post-Traumatic Stress Disorder, Anxiety Disorders, or Mood Disorders: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Accelerated Resolution Therapy for Post-Traumatic Stress Disorder, Anxiety Disorders, or Mood Disorders: Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Accelerated Resolution Therapy for Post-Traumatic Stress Disorder, Anxiety Disorders, or Mood Disorders: Clinical Effectiveness (...) , Cost-Effectiveness, and Guidelines Accelerated Resolution Therapy for Post-Traumatic Stress Disorder, Anxiety Disorders, or Mood Disorders: Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated: September 19, 2019 Project Number: RB1404-000 Product Line: Research Type: Non-Pharma Mental Health Intervention Report Type: Summary of Abstracts Result type: Report Question What is the clinical effectiveness of Accelerated Resolution Therapy (ART) for the treatment of adults with post

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

10. Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders

Systematic Review - Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders 4 March 2019 Prepared for: Department of Veterans Affairs Veterans Health Administration Health Services Research & Development Service Washington, DC 20420 Prepared by: Evidence Synthesis Program (ESP) Center Portland VA Medical Center Portland, OR Mark Helfand, MD, MPH, MS, Director (...) Relationship of Deployment-related Mild Traumatic Brain Injury to Posttraumatic Stress Disorder, Depressive Disorders, Substance Use Disorders, Suicidal Ideation, and Anxiety Disorders: A Systematic Review Authors: Principal Investigator: Nancy Greer, PhD Timothy J. Wilt, MD, MPH Co-Investigators: Princess Ackland, PhD, MSPH Roderick MacDonald, MS Nina Sayer, PhD Michele Spoont, PhD Brent Taylor, PhD Research Assistants: Lauren McKenzie, MPH Christina Rosebush, MPH Evidence Synthesis Program 4 Relationship

2019 Veterans Affairs Evidence-based Synthesis Program Reports

11. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders

Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Search Search A A A Evidence to Improve Care Share: Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders Final Recommendation Health Quality Ontario, under the guidance of the Ontario (...) Health Technology Advisory Committee, recommends publicly funding guided internet-delivered cognitive behavioural therapy for mild to moderate major depression and anxiety disorders Cognitive behavioural therapy (or “CBT”) is a form of psychotherapy that has proven effective in treating major depression and anxiety disorders. However, it can often be difficult for people to access this therapy because of long wait times, the cost of sessions, and travel time to get to sessions. Cognitive behavioural

2019 Health Quality Ontario

12. Coping With Stress, Anxiety, And Substance Use During Covid-19

Coping With Stress, Anxiety, And Substance Use During Covid-19 Coping With Stress, Anxiety, And Substance Use During Covid-19 [infographic] | Canadian Centre on Substance Use and Addiction Browse and – trusted sources for your information and research needs. Search the CCSA website Search Substances and Addiction SPOTLIGHT Health and Public Safety SPOTLIGHT People and Communities SPOTLIGHT Data Trends SPOTLIGHT About Us SPOTLIGHT Menu Search the CCSA website Search Substances and Addiction (...) SPOTLIGHT Health and Public Safety SPOTLIGHT People and Communities SPOTLIGHT Data Trends SPOTLIGHT About Us SPOTLIGHT Breadcrumb Coping With Stress, Anxiety, And Substance Use During Covid-19 [infographic] Share Infographic Coping With Stress, Anxiety, And Substance Use During Covid-19 [infographic] Publication date: 2020 Author: Canadian Centre on Substance Use and Addiction; Mental Health Commission of Canada Overview of facts, tips and resources to help Canadians cope with stress, anxiety

2020 Canadian Centre on Substance Abuse

13. The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review Full Text available with Trip Pro

The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review - Murray - 2019 - Campbell Systematic Reviews - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term SYSTEMATIC REVIEW Open Access The impact of care farms (...) on quality of life, depression and anxiety among different population groups: A systematic review Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK Plant Research International, Wageningen University, Wageningen, The Netherlands Care Farming UK, Bedminster, UK Academic Unit of Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

2019 Campbell Collaboration

14. Generalised anxiety disorder

Generalised anxiety disorder Generalised anxiety disorder - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Generalised anxiety disorder Last reviewed: February 2019 Last updated: September 2018 Summary Common condition defined as chronic, excessive worry for at least 6 months that causes distress or impairment. At least 3 key symptoms out of a possible 6 are required to make a diagnosis: restlessness or nervousness (...) , easy fatigability, poor concentration, irritability, muscle tension, or sleep disturbance. It is in part a diagnosis of exclusion: medical conditions, medications or substances, and other mental disorders should be ruled out as a primary cause. Physical examination and laboratory studies are generally normal if no co-existing medical problems or substance abuse issues exist. Treatment is with either pharmacotherapy, psychotherapy, or a combination. Definition Generalised anxiety disorder (GAD

2018 BMJ Best Practice

15. Social anxiety disorder

Social anxiety disorder Social anxiety disorder - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Social anxiety disorder Last reviewed: February 2019 Last updated: July 2018 Summary Characterised by an excessive fear of social and performance situations where the individual is afraid of being embarrassed or negatively evaluated by others. One of the most common and impairing mental disorders with a high risk (...) for comorbid anxiety, depressive, and substance-use/abuse-related disorders. Assessment is based on self-reporting, clinical interview, and behavioural observation. Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and cognitive behavioural therapy are considered the first-line treatments. Long-term clinical management and monitoring are typically required, as patients are prone to relapse following discontinuation of acute treatment. Definition The condition involves

2018 BMJ Best Practice

16. Generalised anxiety disorder

Generalised anxiety disorder Generalised anxiety disorder - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Generalised anxiety disorder Last reviewed: February 2019 Last updated: September 2018 Summary Common condition defined as chronic, excessive worry for at least 6 months that causes distress or impairment. At least 3 key symptoms out of a possible 6 are required to make a diagnosis: restlessness or nervousness (...) , easy fatigability, poor concentration, irritability, muscle tension, or sleep disturbance. It is in part a diagnosis of exclusion: medical conditions, medications or substances, and other mental disorders should be ruled out as a primary cause. Physical examination and laboratory studies are generally normal if no co-existing medical problems or substance abuse issues exist. Treatment is with either pharmacotherapy, psychotherapy, or a combination. Definition Generalised anxiety disorder (GAD

2018 BMJ Best Practice

17. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder Full Text available with Trip Pro

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published treatment guidelines for bipolar disorder in 2005, along with international commentaries and subsequent updates in 2007, 2009, and 2013. The last two updates were published in collaboration with the International Society for Bipolar (...) of the reproductive cycle, children and adolescents, and older adults. There are also discussions on the impact of specific psychiatric and medical comorbidities such as substance use, anxiety, and metabolic disorders. Finally, an overview of issues related to safety and monitoring is provided. The CANMAT and ISBD groups hope that these guidelines become a valuable tool for practitioners across the globe.© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

2018 CPG Infobase

18. Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies

Guidance on the clinical management of anxiety disorders, specifically focusing on diagnosis and treatment strategies Objective: To provide practical clinical guidance for the treatment of adults with panic disorder, social anxiety disorder and generalised anxiety disorder in Australia and New Zealand. Method: Relevant systematic reviews and meta-analyses of clinical trials were identified by searching PsycINFO, Med- line, Embase and Cochrane databases. Additional relevant studies were (...) , professional bodies, and specialist groups with interest and expertise in anxiety disorders. Results: The guidelines recommend a pragmatic approach beginning with psychoeducation and advice on lifestyle fac- tors, followed by initial treatment selected in collaboration with the patient from evidence-based options, taking into account symptom severity, patient preference, accessibility and cost. Recommended initial treatment options for all three anxiety disorders are cognitive–behavioural therapy (face

2018 Royal Australian and New Zealand College of Psychiatrists

19. Management of Acute Anxiety in the Pre-Hospital Setting: Guidelines

Management of Acute Anxiety in the Pre-Hospital Setting: Guidelines Management of Acute Anxiety in the Pre-Hospital Setting: Guidelines | CADTH.ca Find the information you need Management of Acute Anxiety in the Pre-Hospital Setting: Guidelines Management of Acute Anxiety in the Pre-Hospital Setting: Guidelines Last updated: February 8, 2018 Project Number: RB1193-000 Product Line: Research Type: Drug Report Type: Summary of Abstracts Result type: Report Question What are the evidence-based (...) guidelines for the management of acute anxiety for patients in pre-hospital settings? Key Message No relevant literature was identified regarding the management of acute anxiety for patients in pre-hospital settings. Files Rapid Response Summary of Abstracts Published : February 8, 2018 Related Content Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

20. Neurofeedback for Mood and Anxiety Disorders: Clinical Effectiveness

Neurofeedback for Mood and Anxiety Disorders: Clinical Effectiveness Neurofeedback for Mood and Anxiety Disorders: Clinical Effectiveness | CADTH.ca Find the information you need Neurofeedback for Mood and Anxiety Disorders: Clinical Effectiveness Neurofeedback for Mood and Anxiety Disorders: Clinical Effectiveness Last updated: February 28, 2018 Project Number: RB1198-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What (...) is the comparative clinical effectiveness of dynamical neurofeedback versus neurofeedback for mood or anxiety disorders in adults? What is the clinical effectiveness of telehealth-delivered neurofeedback for mood or anxiety disorders in adults? What is the clinical effectiveness of neurofeedback for the families of patients receiving neurofeedback for mood or anxiety disorders? Key Message No relevant literature was identified regarding the comparative clinical effectiveness of dynamical neurofeedback versus

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review